Veterinary Medicines

Benestermycin suspensija ievadīšanai tesmenī liellopiem

Authorised
  • Benethamine penicillin
  • Framycetin sulfate
  • Penethamate hydriodide
Download as PDF

Product identification

Medicine name:
Benestermycin suspensija ievadīšanai tesmenī liellopiem
Active substance:
  • Benethamine penicillin
  • Framycetin sulfate
  • Penethamate hydriodide
Target species:
  • Cattle (dry cow)
Route of administration:
  • Intramammary use

Product details

Active substance and strength:
  • Benethamine penicillin
    280.00
    milligram(s)
    /
    1.00
    Syringe
  • Framycetin sulfate
    100.00
    milligram(s)
    /
    1.00
    Syringe
  • Penethamate hydriodide
    100.00
    milligram(s)
    /
    1.00
    Syringe
Pharmaceutical form:
  • Intramammary suspension
Withdrawal period by route of administration:
  • Intramammary use
    • Cattle (dry cow)
      • Meat and offal
        8
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ51RC25
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Latvia
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application - Known active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Boehringer Ingelheim Vetmedica GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • Haupt Pharma Latina S.r.l.
  • Lohmann Pharma Herstellung GmbH
Responsible authority:
  • Food And Veterinary Service
Authorisation number:
  • V/NRP/96/0294
Date of authorisation status change:

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Latvian (PDF)
Published on: 3/06/2024
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."